June 2, 2016
Kite Pharma (KITE) lights the fire, warming shareholders +$1.98 to $52.85
May 31, 2016
StemCells (STEM) toes-up, drops -79.21% to $0.63 from Friday's close of $3.03
May 16, 2016
Biostage (BSTG) - $5 M At-The-Market offering of 2.8 M shares at $1.7625
April 5, 2016
RegMed Investors: Beyond the news, don’t miss access to timely and actionable information
April 1, 2016
RegMed Investors (RMi) it’s time to act on subscription!
March 24, 2016
RegMed Investors (RMi) it’s time to act on subscription!
March 22, 2016
RegMed Investors’ (RMi) motto: Never leave an investor uninformed
February 24, 2016
RegMed Investors (RMi) can you afford to miss the insider view …
February 23, 2016
RegMed Investors (RMi): Seeking better returns? Invest in actionable intelligence and interpretation!
February 17, 2016
RegMed Investors’ (RMi) motto is: Never leave an investor uninformed
February 15, 2016
RegMed Investors’ (RMi) motto is: Never leave an investor uninformed
February 11, 2016
RegMed Investors’ (RMi) motto is: Never leave an investor uninformed
February 8, 2016
RegMed Investors’ (RMi) motto is: Never leave an investor uninformed
February 2, 2016
RegMed Investors’ (RMi) Never leave an investor uninformed
January 28, 2016
RegMed’s mid-day: stocks struggle
January 26, 2016
RegMed’s mid-day: volatility sinks sector but, the Advance/Decline Line breach is decreasing
January 22, 2016
RegMed Investors’ (RMi) context, interpretation and pricing metrics define the expectation
January 15, 2016
RegMed’s mid-day: the sector is extremely oversold
January 14, 2016
RegMed’s mid-day: we’re UP; the JPM/SF limbo line bar was raised
January 12, 2016
The market has NOT been kind ...
January 4, 2016
Cash in on RegMed Investors’ content, context, interpretation and pricing metrics
November 26, 2015
Happy Thanksgiving ... giving thanks and be SAFE!
November 5, 2015
RegMed’s mid-day: support breaks down
November 3, 2015
Re-framing the main takeaway … pricing, volume and volatility!
October 26, 2015
RegMed’s mid-day: riding the bucking bronco
9 hours 11 min ago
RegMed Investors’ (RMi) pre-open: the oversold shall rise again
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his thirteenth (13th) year at RegMed Investors
© 2020 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.